📗 Cite This Artifact
KCNJ3 Gene
KCNJ3 Gene
Introduction
KCNJ3 (Kir3.1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@katp]
title: KCNJ3 Gene [@neural]
description: Gene page for Potassium Inward Rectifier Channel 3 [@atga]
--- [@caspase]
<div class="infobox infobox-gene"> [@girk]
| | | [@amyloidbeta]
|---|---| [@neuronal]
| Gene Symbol | KCNJ3 | [@girka]
| Full Name | KCNJ3 - Potassium Voltage-Gated Channel Subfamily J Member 3 | [@basal]
| Chromosomal Location | 2q24.1 | [@kcnj]
| NCBI Gene ID | [3760](https://www.ncbi.nlm.nih.gov/gene/3760) | [@novo]
| OMIM | [601534](https://www.omim.org/entry/601534) | [@girkb]
| Ensembl ID | ENSG00000163069 | [@kcnja]
| UniProt ID | [P48547](https://www.uniprot.org/uniprot/P48547) |
</div>
Overview
...KCNJ3 Gene
Introduction
KCNJ3 (Kir3.1) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@katp]
title: KCNJ3 Gene [@neural]
description: Gene page for Potassium Inward Rectifier Channel 3 [@atga]
--- [@caspase]
<div class="infobox infobox-gene"> [@girk]
| | | [@amyloidbeta]
|---|---| [@neuronal]
| Gene Symbol | KCNJ3 | [@girka]
| Full Name | KCNJ3 - Potassium Voltage-Gated Channel Subfamily J Member 3 | [@basal]
| Chromosomal Location | 2q24.1 | [@kcnj]
| NCBI Gene ID | [3760](https://www.ncbi.nlm.nih.gov/gene/3760) | [@novo]
| OMIM | [601534](https://www.omim.org/entry/601534) | [@girkb]
| Ensembl ID | ENSG00000163069 | [@kcnja]
| UniProt ID | [P48547](https://www.uniprot.org/uniprot/P48547) |
</div>
Overview
KCNJ3 encodes Kir3.1 (also known as GIRK1), an inward-rectifier potassium channel that mediates G-protein-activated potassium currents. These channels play critical roles in regulating neuronal excitability, synaptic integration, and signal transduction throughout the central nervous system. Kir3.1 forms heterotetramers with other Kir3.x subunits to create diverse neuronal potassium conductances with distinct pharmacological and biophysical properties [1][2].
Protein Structure and Domain Architecture
Kir3.1 is a member of the inward-rectifier potassium channel (Kir) family, characterized by a distinctive structure optimized for K⁺ selectivity and inward rectification:
- Transmembrane Domains: Two transmembrane helices (M1 and M2) that span the neuronal membrane
- Pore Region (H5/P-loop): Located between M1 and M2, contains the K⁺ selectivity filter (GYG motif)
- N-terminus: Contains the Gβγ binding site and regulates channel trafficking
- C-terminus: Contains the PIP₂ binding site essential for channel activation, palmitoylation sites, and PDZ-domain interactions
The channel assembles as a tetramer, with each subunit contributing to the central pore. Heterotetramerization with Kir3.2 (KCNJ6), Kir3.3 (KCNJ7), or Kir3.4 (KCNJ5) generates channels with distinct properties [1][2].
Normal Function
G-Protein Activation Mechanism
Kir3.1 channels are activated by GPCR signaling through a well-characterized mechanism:
Regional Distribution and Function
- [Hippocampus](/brain-regions/hippocampus): Kir3.1/3.2 channels regulateCA1 pyramidal neuron excitability, synaptic plasticity ([LTP](/mechanisms/long-term-potentiation)/LTD), and hippocampal-dependent learning and memory [3][4]
- Basal Ganglia: Critical modulation of dopaminergic neuron firing in substantia nigra pars compacta (SNc) and ventral tegmental area (VTA); regulates reward processing5]
- and motor control [Cerebellum: Modulates Purkinje cell output and cerebellar learning; regulates inhibitory interneuron function [6]
- [Cortex](/brain-regions/cortex): Controls pyramidal neuron excitability and sensory integration
- Thalamus: Regulates relay neuron firing patterns and sensory transmission
Physiological Roles
- Resting Membrane Potential: Establishes and maintains the negative resting membrane potential (~-70mV in neurons)
- Neuronal Excitability: Hyperpolarizing current reduces action potential frequency and prevents hyperexcitability
- Synaptic Integration: Attenuates excitatory postsynaptic potentials and shapes temporal summation
- Neurotransmitter Release: Presynaptic Kir3.x channels regulate Ca²⁺ entry and neurotransmitter release
- Cardiac Pacemaking: In the heart, Kir3.1/3.4 (if present) modulates automaticity (species-specific)
Disease Associations
Alzheimer's Disease
KCNJ3 dysfunction contributes to Alzheimer's disease through multiple mechanisms:
- Neuronal Hyperexcitability: Reduced Kir3.1 function leads to increased excitability, contributing to epileptiform activity observed in AD patients [7][8]
- Calcium Dysregulation: Altered membrane potential affects voltage-gated calcium channel function and intracellular calcium homeostasis
- Synaptic Dysfunction: Impaired regulation of synaptic plasticity contributes to memory deficits
- [Amyloid-beta](/proteins/amyloid-beta) Effects: Aβ₄₂ directly inhibits Kir3.x currents in hippocampal [neurons](/entities/neurons) [9]
- Therapeutic Targeting: Kir3.x activators represent a potential approach to restore normal excitability
Parkinson's Disease
Kir3.1 plays a critical role in dopaminergic neuron function:
- Dopaminergic Regulation: Kir3.1/3.2 channels modulate the firing rate and pattern of SNc dopaminergic neurons [5]
- Motor Control: Dysregulation contributes to motor circuit dysfunction
- Levodopa-Induced Dyskinesia: Altered Kir3.x signaling in the basal ganglia may contribute to L-DOPA-induced dyskinesias [10]
- Neuroprotection: Targeting Kir3.x may provide neuroprotective effects in PD models
Epilepsy
KCNJ3 mutations and dysfunction are directly linked to epileptic disorders:
- Loss-of-Function Mutations: Biallelic KCNJ3 mutations cause early-onset epileptic encephalopathy with developmental delay [11][12]
- Hyperexcitability: Reduced K⁺ conductance leads to neuronal hyperexcitability and seizure generation
- Therapeutic Implications: Kir3.x activators (e.g.,, retigabine analogs) represent anticonvulsant strategies
Ataxia and Cerebellar Disorders
- Cerebellar Dysfunction: Kir3.1 regulates Purkinje cell output; dysfunction contributes to ataxic movements [6]
- Developmental Ataxia: Mutations affecting channel trafficking or function cause congenital ataxia
- Spinocerebellar Ataxia: Although not a primary SCA gene, Kir3.x dysfunction may modify disease progression
Neuropathic Pain
- Peripheral Sensitization: Kir3.x channels in dorsal root ganglion neurons regulate pain signaling
- Central Pain Pathways: Spinal and supraspinal Kir3.x modulation affects pain perception
- Therapeutic Potential: Kir3.x activators may reduce chronic pain states
Psychiatric Disorders
- Depression: Altered Kir3.x function in prefrontal cortex and hippocampus may contribute to mood disorders [13]
- Addiction: Modulation of reward circuitry via VTA Kir3.x channels affects addiction-related behaviors
- Schizophrenia: Altered GABAergic modulation via Kir3.x may contribute to working memory deficits
Therapeutic Implications
Drug Development
- Kir3.x Activators: Small molecules that enhance Kir3.x opening (e.g.,, retigabine derivatives) for hyperexcitability disorders
- GPCR-Targeted Approaches: Modulating upstream GPCRs (m₂, D₂, GABA-B) to indirectly activate Kir3.x
- Gene Therapy: Viral vector delivery of KCNJ3 to restore channel expression
Research Tools
- KCNJ3 Knockout Mice: Exhibit hyperexcitability, seizures, and learning deficits [14]
- Channel Blockers: Tertiapin-Q used experimentally to study Kir3.x function
- Optogenetic Approaches: Light-activated Kir3.x variants for precise neuronal control
Interaction Network
Protein-Protein Interactions
- KCNJ6 (Kir3.2): Primary heterotetramerization partner in most brain regions
- KCNJ5 (Kir3.4): Forms heterotetramers in heart and some brain regions
- RGS Proteins: RGS6, RGS7, RGS9, RGS20 regulate Kir3.x signaling via GAP activity
- Gβγ Subunits: Direct activation by released Gβγ
- PIP₂: Essential phospholipid cofactor for channel function
- 14-3-3 Proteins: Regulate trafficking and surface expression
- Filamin A: Scaffolding protein that localizes Kir3.x to specific membrane domains
Signaling Pathways
- GPCR Signaling: Kir3.x as downstream effector of muscarinic, dopaminergic, serotonergic, GABAergic, and opioid signaling
- cAMP/PKA: PKA phosphorylation can modulate channel activity
- PI3K/Akt: Akt can phosphorylate and regulate Kir3.x function
- MAPK/ERK: Activity-dependent modulation contributes to synaptic plasticity
Animal Models
- KCNJ3 Knockout Mice: Show spontaneous seizures, enhanced hippocampal excitability, impaired spatial learning, and altered reward responses [14]
- KCNJ3/KCNJ6 Double Knockout: Severe neurological phenotype with early mortality
- Transgenic Overexpression: Increased K⁺ conductance, reduced excitability, seizure protection
Clinical Relevance
Genetic Testing
- KCNJ3 variants associated with epilepsy and developmental disorders can be identified via clinical exome sequencing
Biomarker Potential
- CSF or blood Kir3.x channel expression may serve as a biomarker for neurodegenerative disease progression
- Functional assays measuring Kir3.x current in patient-derived neurons could predict drug responses
Background
The study of Kcnj3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- Kir3.2 Protein
- [Ion Channels in Neurodegeneration](/mechanisms/ion-channel-dysfunction)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
- Gene Therapies for Neurodegeneration
- Small Molecule Approaches
External Links
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/3760)
- [UniProt](https://www.uniprot.org/uniprot/P48547)
- [GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNJ3)
- [Human Protein Atlas](https://www.proteinatlas.org/ENSG00000163069-KCNJ3)
- [PharmGKB](https://www.pharmgkb.org/gene/PA30019)
References
Pathway Diagram
The following diagram shows the key molecular relationships involving KCNJ3 Gene discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-kcnj3 |
| kg_node_id | KCNJ3 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-a54e5502cb31 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-kcnj3'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-kcnj3?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[KCNJ3 Gene](http://scidex.ai/artifact/wiki-genes-kcnj3)
http://scidex.ai/artifact/wiki-genes-kcnj3